Location History:
- Shimotsuga, JP (1994)
- Mibumachi, JP (2007)
- Tochigi, JP (1993 - 2009)
Company Filing History:
6 out of 613 
3 out of 200 
3 out of 441 
Years Active: 1993-2009
Title: The Innovative Contributions of Tomonori Morinaga
Introduction
Tomonori Morinaga is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of biomedical research, particularly in the area of bone health. With a total of 13 patents to his name, Morinaga's work focuses on innovative methods for treating bone diseases.
Latest Patents
Morinaga's latest patents include groundbreaking methods for reducing bone absorption through the administration of antibodies that bind to osteoclastogenesis inhibitory factor (OCIF). His inventions also encompass novel proteins and polypeptides that interact with OCIF-binding molecules (OBMs). These advancements provide processes for producing these proteins and nucleic acids via genetic engineering. Additionally, he has developed medicinal compounds that include proteins and nucleic acids, which can be utilized in the treatment of various bone diseases. One of his notable proteins inhibits osteoclast differentiation and maturation, showcasing a molecular weight of approximately 60 kD and 120 kD under different conditions. This protein can be isolated from the culture medium of human embryonic lung fibroblasts, and its production can also be achieved through gene engineering.
Career Highlights
Throughout his career, Morinaga has worked with esteemed companies such as Sankyo Company, Limited and Snow Brand Milk Products Co., Ltd. His innovative research has positioned him as a key figure in the development of therapeutic solutions for bone-related ailments.
Collaborations
Morinaga has collaborated with notable professionals in his field, including Kanji Higashio and Masaaki Goto. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Tomonori Morinaga's contributions to the field of biomedical research, particularly in bone health, are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for bone diseases.